Treatment of Barrett’s esophagus with high-grade dysplasia

References

• Spechler SJ. Clinical practice. Barrett’s Esophagus. N. Engl. J. Med.346(11), 836–842 (2002).
   PubMed Web of Science ®Google Scholar
• Hameeteman W, Tytgat GN, Houthoff HF et al. Barrett’s esophagus: development of dysplasia and adenocarcinoma. Gastroenterology96(5), 1249–1256 (1989).
   PubMed Web of Science ®Google Scholar
• Skinner DB, Walther BC, Riddell RH et al. Barrett’s esophagus. Comparison of benign and malignant cases. Ann. Surg.198(4), 554–565 (1983).
   PubMed Web of Science ®Google Scholar
• Smith RR, Hamilton SR, Boitnott JK et al. The spectrum of carcinoma arising in Barrett’s esophagus. A clinicopathologic study of 26 patients. Am. J. Surg. Pathol.8(8), 563–573 (1984).
   PubMed Web of Science ®Google Scholar
• Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett’s esophagus. Am. J. Clin. Pathol.87(3), 301–312 (1987).
   PubMed Web of Science ®Google Scholar
• Theisen J, Nigro JJ, DeMeester TR. Chronology of the Barrett’s metaplasia–dysplasia–carcinoma sequence. Dis. Esophagus17(1), 67–70 (2004).
   PubMedGoogle Scholar
• Levine DS. Management of dysplasia in the columnar-lined esophagus. Gastroenterol. Clin. North Am.26(3), 613–634 (1997).
   PubMedGoogle Scholar
• Thomas T, Richards CJ, de Caestecker JS et al. High-grade dysplasia in Barrett’s oesophagus: natural history and review of clinical practice. Aliment. Pharmacol. Ther.21(6), 747–755 (2005).
   PubMedGoogle Scholar
• Haggitt RC. Barrett’s esophagus, dysplasia, and adenocarcinoma. Hum. Pathol.25(10), 982–993 (1994).
   PubMed Web of Science ®Google Scholar
• Sharma P, Falk GW, Weston AP et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett’s esophagus. Clin. Gastroenterol. Hepatol.4(5), 566–572 (2006).
   PubMed Web of Science ®Google Scholar
• Dulai GS, Shekelle PG, Jensen DM et al. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett’s cohort. Am. J. Gastroenterol.100(4), 775–783 (2005).
   PubMedGoogle Scholar
• Puli S, Rastogi A, Mathur S et al. Development of esophagal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia undergoing surveillance: a meta-analysis and systematic review. Gastrointest. Endosc.63, AB83 (2006).
   Google Scholar
• Reid BJ, Levine DS, Longton G et al. Predictors of progression to cancer in Barrett’s esophagus: baseline histology and flow cytometry identify low and high risk patient subsets. Am. J. Gastroenterol.95, 1669–1676 (2000).
   PubMed Web of Science ®Google Scholar
• Rice TW, Falk GW, Achkar E et al. Surgical management of high-grade dysplasia in Barrett’s esophagus. Am. J. Gastroenterol.88(11), 1811–1812 (1993).
   PubMedGoogle Scholar
• Zaninotto G, Parenti AR, Ruol A et al. Oesophageal resection for high-grade dysplasia in Barrett’s oesophagus. Br. J. Surg.87(8), 1102–1105 (2000).
   PubMed Web of Science ®Google Scholar
• Pera M, Trastek VF, Carpenter HA et al. Barrett’s esophagus with high-grade dysplasia: an indication for esophagectomy? Ann. Thorac. Surg.54(2), 199–204 (1992).
   PubMed Web of Science ®Google Scholar
• Wright TA. High-grade dysplasia in Barrett’s oesophagus. Br. J. Surg.84(6), 760–766 (1997).
   PubMedGoogle Scholar
• Al-Kasspooles MF, Hill HC, Nava HR et al. High-grade dysplasia within Barrett’s esophagus: controversies regarding clinical opinions and approaches. Ann. Surg. Oncol.9(3), 222–227 (2002).
   PubMedGoogle Scholar
• Reid BJ, Blount PL, Fenz Z et al. Optimizing endoscopic biopsy detection of early cancers in Barrett’s high-grade dysplasia. Am. J. Gastroenterol.95(11), 3089–3096 (2000).
   PubMed Web of Science ®Google Scholar
• Williams VA, Watson TJ, Herbella FA et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J. Gastrointest. Surg.11(12), 1589–1597 (2007).
   PubMed Web of Science ®Google Scholar
• Reid BJ, Haggitt RC, Rubin CE et al. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum. Pathol.19, 166–178 (1988).
   PubMed Web of Science ®Google Scholar
• Montgomery E, Bronner MP, Goldblum JR et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. Hum. Pathol.32, 368–378 (2001).
   PubMed Web of Science ®Google Scholar
• Downs-Kelly E, Mendelin JE, Benne AE et al. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett’s esophagus biopsies. Am. J. Gastroenterol.103(9), 2333–2340 (2008).
   PubMedGoogle Scholar
• Moraca RJ, Low DE. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch. Surg.141(6), 545–549 (2006).
   PubMedGoogle Scholar
• Schembre DB, Huang JL, Lin OS et al. Treatment of Barrett’s esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest. Endosc.67(4), 595–601 (2008).
   PubMed Web of Science ®Google Scholar
• Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett’s esophagus. Does it help? J. Thorac. Cardiovasc. Surg.105(3), 383–387 (1993).
   PubMed Web of Science ®Google Scholar
• Peters JH, Clark GW, Ireland AP et al. Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J. Thorac. Cardiovasc. Surg.108(5), 813–821 (1994).
   PubMed Web of Science ®Google Scholar
• DeMeester TR, Attwood SE, Smyrk TC et al. Surgical therapy in Barrett’s esophagus. Ann. Surg.212(4), 528–540 (1990).
   PubMedGoogle Scholar
• Lerut T, Coosemans W, Van Raemdonck D et al. Surgical treatment of Barrett’s carcinoma. Correlations between morphologic findings and prognosis. J. Thorac. Cardiovasc. Surg.107(4), 1059–1065 (1994).
   PubMed Web of Science ®Google Scholar
• Chang AC, Birkmeyer JD. The volume–performance relationship in esophagectomy. Thorac. Surg. Clin.16, 87–94 (2006).
   PubMedGoogle Scholar
• Swisher SG, Deford L, Merriman KW et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J. Thorac. Cardiovasc. Surg.119(6), 1126–1132 (2000).
   PubMed Web of Science ®Google Scholar
• Birkmeyer JD, Finlayson EVA, Stukel TA et al. Hospital volume and surgical mortality in the United States. N. Engl. J. Med.346, 1128–1137 (2002).
   PubMed Web of Science ®Google Scholar
• Dimick JB, Cowan JA, Ailawadi G et al. National variation in operative mortality rates for esophageal resection and the need for quality improvement. Arch. Surg.138, 1305–1309 (2003).
   PubMedGoogle Scholar
• Birkmyer JD, Stukel TA, Siewers AE et al. Surgeon volume and operative mortality in the United States. N. Engl. J. Med.349, 2117–2127 (2003).
   PubMedGoogle Scholar
• Cuschieri A. Endoscopic subtotal oesophagectomy for cancer using the right thoracoscopic approach. Surg. Oncol.2(Suppl. 1), 3–11 (1993).
   PubMedGoogle Scholar
• Qureshi I, Nason KS, Luketich JD. Is minimally invasive esophagectomy indicated for cancer? Expert Rev. Anticancer Ther.8(9), 1449–1460 (2008).
   PubMed Web of Science ®Google Scholar
• Luketich JD, Alvelo-Rivera M, Buenaventura PO et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann. Surg.238(4), 486–494 (2003).
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Hinojosa MW, Smith BR, Chang KJ, Gray J, Hoyt D. Minimally invasive esophagectomy: lessons learned from 104 operations. Ann. Surg.248(6), 1081–1091 (2008).
   PubMedGoogle Scholar
• Nguyen NT, Follette DM, Wolfe BM, Schneider PD, Roberts P, Goodnight JE Jr. Comparison of minimally invasive esophagectomy with transthoracic and transhiatal esophagectomy. Arch. Surg.135(8), 920–925 (2000).
   PubMedGoogle Scholar
• Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett’s esophagus with and without dysplasia. Dis. Esophagus20(6), 516–522 (2007).
   PubMed Web of Science ®Google Scholar
• Dumoulin FL, Terjung B, Neubrand M, Scheurlen C, Fischer HP, Sauerbruch T. Treatment of Barrett’s esophagus by endoscopic argon plasma coagulation. Endoscopy29, 751–753 (1997).
   PubMedGoogle Scholar
• Claydon PE, Ackroyd R. Argon plasma coagulation ablation of Barrett’s esophagus. Scand. J. Gastroenterol.40, 617–628 (2005).
   PubMed Web of Science ®Google Scholar
• Wahab PJ, Mulder CJJ, den Hartog G et al. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences. Endoscopy29, 176–187 (1997).
   PubMedGoogle Scholar
• Grund KE, Storek D, Farin G. Endoscopic argon plasma coagulation (APC): first clinical experiences in flexible endoscopy. Surg. Endoscopy2, 42–46 (1994).
   Google Scholar
• Morris CD, Byrne JP, Armstrong GR, Attwood SE. Prevention of the neoplastic progression of Barrett’s oesphagus by endoscopic argon beam plasma ablation. Br. J. Surg.88(10), 1357–1362 (2001).
   PubMed Web of Science ®Google Scholar
• Kahaleh M, Van Laethem JL, Nagy N et al. Long-term follow-up and factors predictive of recurrence in Barrett’s esophagus treated by argon plasma coagulation and acid suppression. Endoscopy34, 950–955 (2002).
   PubMed Web of Science ®Google Scholar
• Ferraris R, Fracchia M, Foti M et al. Barrett’s oesphagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence. Aliment. Pharmacol. Ther.25(7), 835–840 (2007).
   PubMed Web of Science ®Google Scholar
• Pereira-Lima JC, Busnello JV, Saul C et al. High power setting argon plasma coagulation for the eradication of Barrett’s esophagus. Am. J. Gastroenterol.95, 1661–1668 (2000).
   PubMed Web of Science ®Google Scholar
• Madisch A, Miehlke S, Bayerdorffer E et al. Long-term follow-up after complete ablation of Barrett’s esophagus with argon plasma coagulation. World J. Gastroenterol.11, 1182–1186 (2005).
   PubMed Web of Science ®Google Scholar
• Tigges H, Fuchs KH, Maroske J et al. Comination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett’s esophagus. J. Gastrointest. Surg.5, 251–259 (2001).
   PubMedGoogle Scholar
• Dumoulin FL, Terjung B, Neubrand M et al. Treatment of Barrett’s esophagus by endoscopic argon plasma coagulation. Endoscopy29, 751–753 (1997).
   PubMedGoogle Scholar
• Van Laethem JL, Cremer M, Peny MO et al. Eradication of Barrett’s mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut43(6), 747–751 (1998).
   PubMed Web of Science ®Google Scholar
• Manner H, May A, Miehlke S et al. Ablation of nonneoplastic Barrett’s mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am. J. Gastroenterol.101(8), 1762–1769 (2006).
   PubMed Web of Science ®Google Scholar
• Ackroyd R, Tam W, Schoeman M et al. Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett’s esophagus with antireflux surgery. Gastrointest. Endosc.59(1), 1–7 (2004).
   PubMed Web of Science ®Google Scholar
• Bright T, Watson DI, Tam W et al. Randomized trial of argon plasma coagulation versus endoscopic surveillance for Barrett esophagus after antireflux surgery: late results. Ann. Surg.246(6), 1016–1020 (2007).
   PubMed Web of Science ®Google Scholar
• Attwood SE, Lewis CJ, Caplin S, Hemming K, Armstrong G. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett’s esophagus. Clin. Gastroenterol. Hepatol.1(4), 258–263 (2003).
   PubMed Web of Science ®Google Scholar
• Byrne JP, Armstrong GR, Attwood SE. Restoration of the normal squamous lining in Barrett’s esophagus by argon beam plasma coagulation. Am. J. Gastroenterol.93, 1810–1815 (1998).
   PubMed Web of Science ®Google Scholar
• Morris CD, Byrne JP, Armstrong GR et al. Prevention of the neoplastic progression of Barrett’s esophagus by endoscopic argon beam plasma ablation. Br. J. Surg.88, 1357–1362 (2001).
   PubMed Web of Science ®Google Scholar
• Van Laethem JL, Jagodzinski R, Peny MO et al. Argon plasma coagulation in the treatment of Barrett’s high-grade dysplasia and in situ adenocarcinoma. Endoscopy33, 257–261 (2001).
   PubMedGoogle Scholar
• Van Laetham JL, Peny MO, Salmon I et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett’s oesophagus. Gut46, 574–577 (2000).
   PubMedGoogle Scholar
• Petersen BT, Chuttani R, Croffie J et al. Photodynamic therapy for gastrointestinal disease. Gastrointest. Endosc.63(7), 927–932 (2006).
   PubMedGoogle Scholar
• Wolfsen HC. Present status of photodynamic therapy for high-grade dysplasia in Barrett’s esophagus. J. Clin. Gastroenterol.39(3), 189–202 (2005).
   PubMedGoogle Scholar
• Schuchert MJ, Luketich JD. Barrett’s esophagus – emerging concepts and controversies. J. Surg. Oncol.95(3), 185–189 (2007).
   PubMedGoogle Scholar
• Petersen BT, Chuttani R, Croffie J et al. Photodynamic therapy for gastrointestinal disease. Gastrointest. Endosc.63(7), 927–932 (2006).
   PubMedGoogle Scholar
• Overholt B, Panjehpour M, Tefftellar E et al. Photodynamic therapy for treatment of early adenocarcinoma in Barrett’s esophagus. Gastrointest. Endosc.39(1), 73–76 (1993).
   PubMed Web of Science ®Google Scholar
• Overholt BF, Panjehpour M, Haydek JM. Photodynamic therapy for Barrett’s esophagus: follow-up in 100 patients. Gastrointest. Endosc.49(1), 107 (1999).
   PubMedGoogle Scholar
• Panjehpour M, Overholt BF, Haydek JM et al. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett’s esophagus and effect of oral steroids on stricture formation. Am. J. Gastroenterol.95(9), 2177–2184 (2000).
   PubMed Web of Science ®Google Scholar
• Wolfsen HC, Hemminger LL, Wallace MB et al. Clinical experience of patients undergoing photodynamic therapy for Barrett’s dysplasia or cancer. Aliment. Pharmacol. Ther.20(10), 1125–1131 (2004).
   PubMed Web of Science ®Google Scholar
• Overholt BF, Wang KK, Burdick JS et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett’s high-grade dysplasia. Gastrointest. Endosc.66(3), 460–468 (2007).
   PubMed Web of Science ®Google Scholar
• Ragunath K, Krasner N, Raman VS et al. Endoscopic ablation of dysplastic Barrett’s oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand. J. Gastroenterol.40(7), 750–758 (2005).
   PubMed Web of Science ®Google Scholar
• Li YM, Li L, Yu CH et al. A systematic review and meta-analysis of the treatment for Barrett’s esophagus. Dig. Dis. Sci.53(11), 2837–2846 (2008).
   PubMedGoogle Scholar
• Hernandez JC, Reicher S, Chung D et al. Pilot series of radiofrequency ablation of Barrett’s esophagus with or without dysplasia. Endoscopy40(5), 388–392 (2008).
   PubMed Web of Science ®Google Scholar
• Ganz RA, Utley DS, Stern R et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in human esophagus. Gastrointest. Endosc.60, 1002–1010 (2004).
   PubMedGoogle Scholar
• Ganz RA, Batts K. Pilot human study of a balloon-based electrode for ablation of esophageal epithelium: results in subjects prior to planned esophagectomy. Gastrointest. Endosc.59, AB252 (2004).
   Google Scholar
• Dunkin BJ, Martinez J, Bejarano PA et al. Thin-layer ablation of human esophageal epithelium using bipolar radiofrequency balloon device. Surg. Endosc.20(1), 125–130 (2006).
   PubMed Web of Science ®Google Scholar
• Sharma VK, Overholt B, Wang K et al. A randomized, multi-center evaluation of ablation of nondysplastic short segment Barrett esophagus using BARRX bipolar balloon device: extended follow-up of Ablation of Intestinal metaplasia (AIM-I) Trial. Gastrointest. Endosc.61, T1391 (2005).
   Google Scholar
• Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest. Endosc.68(5), 867–876 (2008).
   PubMed Web of Science ®Google Scholar
• Shaheen NJ, Sharma P, Overholt BF et al. A randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett’s esophagus (BE) containing dysplasia: interim results of the AIM dysplasia trial [abstract]. Gastroenterology.134, A-A37 (2008).
   Google Scholar
• Pouw RE, Sharma VK, Bergman JJ, Fleischer DE. Radiofrequency ablation for total Barrett’s eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy40, 1033–1040 (2008).
   PubMed Web of Science ®Google Scholar
• Ganz RA, Overholt BF, Sharma VK et al. Circumferential ablation of Barret’s esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest. Endosc.68(1), 35–40 (2008).
   PubMed Web of Science ®Google Scholar
• Gondrie JJ, Pouw RE, Sondermeijer CMT et al. Step-wise circumferential and focal ablation of Barrett’s esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy40, 359–369 (2008).
   PubMed Web of Science ®Google Scholar
• Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy40(5), 370–379 (2008).
   PubMed Web of Science ®Google Scholar
• Ahmadi A, Draganov P. Endoscopic mucosal resection in the upper gastrointestinal tract. World J. Gastroenterol.14(13), 1984–1989 (2008).
   PubMedGoogle Scholar
• Rosenberg N. Submucosal saline wheal as safety factor in fulguration of rectal and sigmoid polypi. AMA Arch. Surg.70(1), 120–122 (1955).
   PubMedGoogle Scholar
• Soetikno R, Kaltenback T, Yeh R et al. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J. Clin. Oncol.23(20), 4490–4498 (2005).
   PubMed Web of Science ®Google Scholar
• Seewald S, Ang TL, Soehendra N. Endoscopic mucosal resection of Barrett’s oesophagus containing dysplasia or intramucosal cancer. Postgrad. Med. J.83(980), 367–372 (2007).
   PubMedGoogle Scholar
• Faruqi SA, Arantes V, Bhutani MS. Barrett’s esophagus: current and future role of endosonography and optical coherence tomography. Dis. Esophagus17(2), 118–123 (2004).
   PubMedGoogle Scholar
• Stein HJ, Feith M, Mueller J et al. Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann. Surg.232(6), 733–742 (2000).
   PubMed Web of Science ®Google Scholar
• Nigro JJ, Hagen JA, DeMeester TR et al. Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: implications for therapy. J. Thorac. Cardiovasc. Surg.117(1), 16–23 (1999).
   PubMed Web of Science ®Google Scholar
• Ell C, May A, Gossner L et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology118(4), 670–677 (2000).
   PubMed Web of Science ®Google Scholar
• Ell C, May A, Pech O et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer). Gastrointest. Endosc.65(1), 3–10 (2007).
   PubMed Web of Science ®Google Scholar
• Lopes CV, Hela M, Pesenti C. Circumferential endoscopic resection of Barrett’s esophagus with high-grade dysplasia or early adenocarcinoma. Surg. Endosc.21(5), 820–824 (2007).
   PubMed Web of Science ®Google Scholar
• Peters FP, Kara MA, Rosmolen WD et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett’s esophagus with early neoplasia: a prospective study. Am. J. Gastroenterol.101(7), 1449–1457 (2006).
   PubMed Web of Science ®Google Scholar
• Nijhawan PK, Wang KK. Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus. Gastrointest. Endosc.52(3), 328–332 (2000).
   PubMed Web of Science ®Google Scholar
• Buttar NS, Wang KK, Lutzke LS et al. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett’s esophagus. Gastrointest. Endosc.54, 682–688 (2001).
   PubMed Web of Science ®Google Scholar
• May A, Gossner L, Pech O et al. Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett’s esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy34, 604–610 (2002).
   PubMed Web of Science ®Google Scholar
• May A, Gossner L, Pech O et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett’s oesophagus: acute-phase and intermediate results of a new treatment approach. Eur. J. Gastroenterol. Hepatol.14, 1085–1091 (2002).
   PubMed Web of Science ®Google Scholar
• Peters FP, Kara MA, Rosmolen WD et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett’s esophagus. Gastrointest. Endosc.61(4), 506–514 (2005).
   PubMed Web of Science ®Google Scholar
• Pacifico RJ, Wang KK, Wongkeesong L et al. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett’s esophagus. Clin. Gastroenterol. Hepatol.1, 252–257 (2003).
   PubMed Web of Science ®Google Scholar
• Seewald S, Akaraviputh T, Seitz U et al. Circumferential EMR and complete removal of Barrett’s epithelium: a new approach to management of Barrett’s esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest. Endosc.57(7), 854–859 (2003).
   PubMed Web of Science ®Google Scholar
• Giovannini M, Bories E, Pesenti C et al. Circumferential endoscopic mucosal resection in Barrett’s esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy36(9), 782–787 (2004).
   PubMed Web of Science ®Google Scholar
• Larghi A, Lightdale CJ, Ross AS. Long-term follow-up of complete Barrett’s eradication endoscopic mucosal resection (CBE–EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy39(12), 1086–1091 (2007).
   PubMed Web of Science ®Google Scholar
• Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett’s esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest. Endosc.58(2), 183–188 (2003).
   PubMed Web of Science ®Google Scholar
• Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablatikon of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest. Endosc.65, 185–195 (2007).
   PubMed Web of Science ®Google Scholar